23andMe Holding Co. (ME) DCF Valuation

23andMe Holding Co. (ME) DCF Valuation
  • ✓ Entièrement Modifiable: Adapté À Vos Besoins Dans Excel Ou Sheets
  • ✓ Conception Professionnelle: Modèles Fiables Et Conformes Aux Normes Du Secteur
  • ✓ Pré-Construits Pour Une Utilisation Rapide Et Efficace
  • ✓ Aucune Expertise N'Est Requise; Facile À Suivre

23andMe Holding Co. (ME) Bundle

DCF model
Get Full Bundle:
$25 $15
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7

TOTAL:

Engineered for accuracy, our (ME) DCF Calculator empowers you to evaluate 23andMe Holding Co. valuation using actual financial data, while offering complete flexibility to modify all essential parameters for improved forecasts.


Discounted Cash Flow (DCF) - (USD MM)

Year AY1
2019		 AY2
2020		 AY3
2021		 AY4
2022		 AY5
2023		 FY1
2024		 FY2
2025		 FY3
2026		 FY4
2027		 FY5
2028
Revenue 305.5 243.9 271.9 299.5 219.6 205.8 192.8 180.7 169.3 158.7
Revenue Growth, % 0 -20.15 11.47 10.15 -26.66 -6.3 -6.3 -6.3 -6.3 -6.3
EBITDA -191.5 -165.0 -228.0 -291.9 -291.9 -169.4 -158.8 -148.8 -139.4 -130.6
EBITDA, % -62.69 -67.62 -83.86 -97.48 -132.89 -82.33 -82.33 -82.33 -82.33 -82.33
Depreciation 22.2 20.2 26.1 36.5 29.5 20.9 19.6 18.4 17.2 16.1
Depreciation, % 7.28 8.3 9.62 12.19 13.42 10.16 10.16 10.16 10.16 10.16
EBIT -213.8 -185.2 -254.2 -328.4 -321.4 -180.9 -169.5 -158.8 -148.8 -139.4
EBIT, % -69.98 -75.92 -93.48 -109.67 -146.31 -87.88 -87.88 -87.88 -87.88 -87.88
Total Cash 209.3 282.5 553.2 386.8 217.9 192.5 180.4 169.0 158.4 148.4
Total Cash, percent .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Account Receivables 6.4 2.5 3.4 1.9 9.1
Account Receivables, % 2.09 1.02 1.24 0.63341 4.13
Inventories 14.1 6.2 10.8 10.2 12.5 8.3 7.8 7.3 6.9 6.4
Inventories, % 4.62 2.56 3.97 3.42 5.68 4.05 4.05 4.05 4.05 4.05
Accounts Payable 13.1 12.3 37.9 12.9 11.6 13.5 12.7 11.9 11.1 10.4
Accounts Payable, % 4.28 5.03 13.95 4.32 5.27 6.57 6.57 6.57 6.57 6.57
Capital Expenditure -73.6 -7.4 -14.0 -11.3 -1.1 -15.0 -14.1 -13.2 -12.4 -11.6
Capital Expenditure, % -24.09 -3.02 -5.14 -3.77 -0.51403 -7.31 -7.31 -7.31 -7.31 -7.31
Tax Rate, % -0.01095059 -0.01095059 -0.01095059 -0.01095059 -0.01095059 -0.01095059 -0.01095059 -0.01095059 -0.01095059 -0.01095059
EBITAT -246.5 -184.9 -250.2 -325.5 -321.4 -179.9 -168.6 -158.0 -148.0 -138.7
Depreciation
Changes in Account Receivables
Changes in Inventories
Changes in Accounts Payable
Capital Expenditure
UFCF -305.3 -161.1 -217.8 -323.3 -303.8 -162.6 -163.2 -152.9 -143.3 -134.2
WACC, % 7.46 7.46 7.43 7.45 7.46 7.45 7.45 7.45 7.45 7.45
PV UFCF
SUM PV UFCF -617.1
Long Term Growth Rate, % 2.00
Free cash flow (T + 1) -137
Terminal Value -2,511
Present Terminal Value -1,753
Enterprise Value -2,370
Net Debt -140
Equity Value -2,230
Diluted Shares Outstanding, MM 24
Equity Value Per Share -93.69

What You Will Get

  • Comprehensive 23andMe Data: Access historical and projected genetic research insights for informed decision-making.
  • Customizable Parameters: Adjust variables such as research funding, growth rates, and market penetration.
  • Dynamic Calculations: Key metrics like market potential and ROI are computed in real-time.
  • Scenario Simulation: Explore various scenarios to assess 23andMe's future growth prospects.
  • User-Friendly Interface: Designed for industry experts but easy for newcomers to navigate.

Key Features

  • Comprehensive Genetic Data: Access to extensive genetic insights and reports.
  • User-Friendly Interface: Simple navigation for users to explore their genetic information.
  • Real-Time Updates: Receive notifications for new discoveries and updates on your genetic data.
  • Visual Representation: Interactive charts and graphs to illustrate genetic traits and ancestry.
  • Designed for Personalization: Tailored health and ancestry reports for individuals seeking deeper insights.

How It Works

  • Download: Obtain the pre-built Excel file containing 23andMe Holding Co.'s (ME) financial data.
  • Customize: Modify projections, including customer growth, revenue margins, and discount rates.
  • Update Automatically: The intrinsic value and NPV calculations refresh in real-time.
  • Test Scenarios: Generate various forecasts and analyze results instantly.
  • Make Decisions: Leverage the valuation insights to inform your investment approach.

Why Choose 23andMe Holding Co. (ME)?

  • Personalized Insights: Gain tailored genetic information that empowers your health decisions.
  • Cutting-Edge Technology: Utilize advanced genetic testing methods for accurate results.
  • Comprehensive Reports: Access detailed reports that cover ancestry, traits, and health risks.
  • User-Friendly Experience: Enjoy an intuitive platform that makes understanding your genetics simple.
  • Backed by Science: Rely on research-driven insights from a trusted leader in genetic testing.

Who Should Use This Product?

  • Genetic Researchers: Develop comprehensive genetic analysis models for study and research purposes.
  • Healthcare Professionals: Evaluate genetic data to inform patient care and treatment strategies.
  • Consultants and Advisors: Offer clients informed insights into genetic testing and its implications for health.
  • Students and Educators: Utilize real-world genetic data to enhance learning and teaching in genetics.
  • Biotech Enthusiasts: Gain an understanding of how companies like 23andMe Holding Co. (ME) are shaping the future of personalized medicine.

What the Template Contains

  • Comprehensive DCF Model: Editable template featuring intricate valuation calculations.
  • Real-World Data: 23andMe's historical and projected financials preloaded for thorough analysis.
  • Customizable Parameters: Modify WACC, growth rates, and tax assumptions to explore various scenarios.
  • Financial Statements: Complete annual and quarterly breakdowns for enhanced insights.
  • Key Ratios: Integrated analysis for profitability, efficiency, and leverage metrics.
  • Dashboard with Visual Outputs: Charts and tables designed for clear, actionable results.

No products were found matching.